Income tax expense · 2017–2025
Kiniksa Pharmaceuticals International income tax expense
$29.9M+324.1% · FY2025
Kiniksa Pharmaceuticals International (KNSA) reported $29.9M in income tax expense for fiscal 2025, +324.1% year on year.
| Fiscal year | Income tax expense | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $29.9M | +324.1% | Open → |
| FY20242024-12-31 | $7.0M | +$37.8M | Open → |
| FY20232023-12-31 | −$30.7M | +$142M | Open → |
| FY20222022-12-31 | −$172M | −$174M | Open → |
| FY20212021-12-31 | $1.4M | −73.1% | Open → |
| FY20202020-12-31 | $5.2M | +$7.2M | Open → |
| FY20192019-12-31 | −$2.0M | −$1.8M | Open → |
| FY20182018-12-31 | −$214,000 | −$216,000 | Open → |
| FY20172017-12-31 | $2,000 | — | Open → |
Income tax expense — Income tax expense is the tax a company charged against profit in its income statement for the year. It is not the same as the cash it handed to tax authorities: deferred tax, provisions and timing differences separate the two, often by billions. The cash figure is a different line in the cash-flow statement.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2017–2025 compound annual growth +232.5%
Income tax expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Kiniksa Pharmaceuticals International income tax expense |url=https://companiesranked.com/en/company/kiniksa-pharmaceuticals-international/income-tax-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Kiniksa Pharmaceuticals International income tax expense. CompaniesRanked. https://companiesranked.com/en/company/kiniksa-pharmaceuticals-international/income-tax-expenseBibTeX
@misc{companiesranked-en-company-kiniksa-pharmaceuticals-international-income-tax-expense-2026,
author = {{CompaniesRanked}},
title = {{Kiniksa Pharmaceuticals International income tax expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/kiniksa-pharmaceuticals-international/income-tax-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001104659-26-019168 · February 24, 2026
{{cite web |title=Kiniksa Pharmaceuticals International income tax expense — 10-K (0001104659-26-019168) |url=https://www.sec.gov/Archives/edgar/data/1730430/000110465926019168/knsa-20251231x10k.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-24}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.